Latest / Evidence at the Bedside
Lupus Nephritis (2024 ACR Guidelines): New Standards in Screening and Triple Therapy
We break down the "Strong Recommendations" for proteinuria screening every 6–12 months, the diagnostic necessity of prompt kidney biopsy, and the shift toward initial triple therapy with calcineurin inhibitors or belimumab. Essential listening for rheumatologists, nephrologists, and internal medicine physicians.
#LupusNephritis #ACR2024 #Rheumatology #Nephrology #MedEd #SLEUpdate #EvidenceAtTheBedside
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.